BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29729131)

  • 21. Holistic Approaches in Lipid Production by Yarrowia lipolytica.
    Lazar Z; Liu N; Stephanopoulos G
    Trends Biotechnol; 2018 Nov; 36(11):1157-1170. PubMed ID: 30006239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome Editing, Transcriptional Regulation, and Forward Genetic Screening Using CRISPR-Cas12a Systems in Yarrowia lipolytica.
    Ramesh A; Lee S; Wheeldon I
    Methods Mol Biol; 2024; 2760():169-198. PubMed ID: 38468089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic engineering in the host Yarrowia lipolytica.
    Abdel-Mawgoud AM; Markham KA; Palmer CM; Liu N; Stephanopoulos G; Alper HS
    Metab Eng; 2018 Nov; 50():192-208. PubMed ID: 30056205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in synthetic biology of oleaginous yeast Yarrowia lipolytica for producing non-native chemicals.
    Darvishi F; Ariana M; Marella ER; Borodina I
    Appl Microbiol Biotechnol; 2018 Jul; 102(14):5925-5938. PubMed ID: 29808327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances and opportunities in gene editing and gene regulation technology for Yarrowia lipolytica.
    Ganesan V; Spagnuolo M; Agrawal A; Smith S; Gao D; Blenner M
    Microb Cell Fact; 2019 Nov; 18(1):208. PubMed ID: 31783869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPRi repression of nonhomologous end-joining for enhanced genome engineering via homologous recombination in Yarrowia lipolytica.
    Schwartz C; Frogue K; Ramesh A; Misa J; Wheeldon I
    Biotechnol Bioeng; 2017 Dec; 114(12):2896-2906. PubMed ID: 28832943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Golden Gate-based metabolic engineering strategy for wild-type strains of Yarrowia lipolytica.
    Egermeier M; Sauer M; Marx H
    FEMS Microbiol Lett; 2019 Feb; 366(4):. PubMed ID: 30698703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A CRISPR/Cas9-Mediated, Homology-Independent Tool Developed for Targeted Genome Integration in Yarrowia lipolytica.
    Cui Z; Zheng H; Zhang J; Jiang Z; Zhu Z; Liu X; Qi Q; Hou J
    Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33452022
    [No Abstract]   [Full Text] [Related]  

  • 29. Advancing Yarrowia lipolytica as a superior biomanufacturing platform by tuning gene expression using promoter engineering.
    Sun ML; Shi TQ; Lin L; Ledesma-Amaro R; Ji XJ
    Bioresour Technol; 2022 Mar; 347():126717. PubMed ID: 35031438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic engineering of Yarrowia lipolytica for the production of isoprene.
    Shaikh KM; Odaneth AA
    Biotechnol Prog; 2021 Nov; 37(6):e3201. PubMed ID: 34369095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A teaching protocol demonstrating the use of EasyClone and CRISPR/Cas9 for metabolic engineering of Saccharomyces cerevisiae and Yarrowia lipolytica.
    Milne N; Tramontin LRR; Borodina I
    FEMS Yeast Res; 2020 Mar; 20(2):. PubMed ID: 31556952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of genome integration sites for developing a CRISPR-based gene expression toolkit in Yarrowia lipolytica.
    Liu X; Cui Z; Su T; Lu X; Hou J; Qi Q
    Microb Biotechnol; 2022 Aug; 15(8):2223-2234. PubMed ID: 35436041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering Yarrowia lipolytica for Use in Biotechnological Applications: A Review of Major Achievements and Recent Innovations.
    Madzak C
    Mol Biotechnol; 2018 Aug; 60(8):621-635. PubMed ID: 29943148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A modular Golden Gate toolkit for Yarrowia lipolytica synthetic biology.
    Larroude M; Park YK; Soudier P; Kubiak M; Nicaud JM; Rossignol T
    Microb Biotechnol; 2019 Nov; 12(6):1249-1259. PubMed ID: 31148366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expansion of YALIcloneHR toolkit for Yarrowia lipolytica combined with Golden Gate and CRISPR technology.
    Shen Q; Yan F; Li YW; Wang J; Ji J; Yan WX; He DC; Song P; Shi TQ
    Biotechnol Lett; 2024 Feb; 46(1):37-46. PubMed ID: 38064043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of cellobiose-degrading ability in Yarrowia lipolytica strain by overexpression of endogenous genes.
    Guo Z; Duquesne S; Bozonnet S; Cioci G; Nicaud JM; Marty A; O'Donohue MJ
    Biotechnol Biofuels; 2015; 8():109. PubMed ID: 26244054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Strong Hybrid Fatty Acid Inducible Transcriptional Sensor Built From Yarrowia lipolytica Upstream Activating and Regulatory Sequences.
    Shabbir Hussain M; Wheeldon I; Blenner MA
    Biotechnol J; 2017 Oct; 12(10):. PubMed ID: 28731568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathway Engineering for Beta-Carotene and Carotenoid Biosynthesis in Y. lipolytica.
    Pesantes-Munoz M; Ledesma-Amaro R
    Methods Mol Biol; 2021; 2307():191-204. PubMed ID: 33847991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Golden-Gate Based Cloning Toolkit to Build Violacein Pathway Libraries in
    Tong Y; Zhou J; Zhang L; Xu P
    ACS Synth Biol; 2021 Jan; 10(1):115-124. PubMed ID: 33399465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homology-independent genome integration enables rapid library construction for enzyme expression and pathway optimization in Yarrowia lipolytica.
    Cui Z; Jiang X; Zheng H; Qi Q; Hou J
    Biotechnol Bioeng; 2019 Feb; 116(2):354-363. PubMed ID: 30418662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.